Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Equipment
Datasets
Search by expertise, name or affiliation
Protocol A8121014: A Phase 2, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Filibuvir Plus Pegylated Interferon Alfa-2A and Ribavirin in Treatment Naive, HCV Genotype 1 Infected subjects
Flamm, Steven L
(PD/PI)
Ganger, Daniel R
(Co-Investigator)
Medicine, Hepatology Division
Project
:
Research project
Overview
Project Details
Status
Finished
Effective start/end date
3/25/10
→
8/31/13
Funding
ICON Clinical Research, LLC
(A8121014)
Pfizer Inc.
(A8121014)
View all
View less